fromsiliconvalleyjournals.com
3 months agoGlox Therapeutics Awarded Share of 3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate
Glox Therapeutics is developing precision antibiotics to address antimicrobial resistance in cystic fibrosis.